Jacob Kingsley MD (He/Him)

Resident Physician•Ann Arbor, MI

Dermatology Resident

Join to View Full Profile

1500 E Medical Center Dr Tc1910Ann Arbor, MI 48109
Phone+1 734-615-6874

Education & Training

University of MichiganResidency, Dermatology, 2024 - 2027
University of Nebraska Medical Center College of MedicineInternship, Internal Medicine, 2022 - 2023
University of Nebraska College of MedicineClass of 2022

Certifications & Licensure

MI State Medical License 2024 - 2025
NE State Medical License 2023 - 2024

Clinical Trials

Evaluation of Efficacy and Safety of VX-548 for Painful Lumbosacral Radiculopathy (PLSR) Start of enrollment: 2023 Dec 13
COMPLETED
PHASE2
A Study of Vaccination With 9-valent Extraintestinal Pathogenic Escherichia Coli Vaccine (ExPEC9V) in the Prevention of Invasive Extraintestinal Pathogenic Escherichia Coli Disease in Adults Aged 60 Years And Older With a History of Urinary Tract Infection in the Past 2 Years Start of enrollment: 2021 Jun 30
RECRUITING
PHASE3
Safety and Efficacy Study of S-309309 in Obese Adults Start of enrollment: 2023 Jun 21
COMPLETED
PHASE2
Study to Evaluate Safety and Immunogenicity of COVID-19 Vaccine in Children 6 Months to < 12 Years Start of enrollment: 2022 Jul 22
ACTIVE_NOT_RECRUITING
PHASE2, PHASE3
A Study to Evaluate the Safety and Immune Response of mRNA-1345, a Vaccine Targeting Respiratory Syncytial Virus (RSV), When Co-administered With a Fluzone HD, in Adults ≥65 Years of Age Start of enrollment: 2023 Sep 25
COMPLETED
PHASE3
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age Start of enrollment: 2021 Oct 26
ACTIVE_NOT_RECRUITING
PHASE3
Study of an Investigational Pentavalent Meningococcal ABCYW Vaccine in Adults and Adolescents Start of enrollment: 2023 Oct 31
ACTIVE_NOT_RECRUITING
PHASE1, PHASE2
Study of a Respiratory Syncytial Virus Candidate Encapsulated in a Lipid Nanoparticle Based Formulation in Adults Aged 18 to 50 Years and 60 Years and Older Start of enrollment: 2022 Nov 17
Active, not recruiting
Phase 1, Phase 2
Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Sub-study: Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Sub-study Start of enrollment: 2022 Dec 16
COMPLETED
PHASE2, PHASE3
Join now to see all

Publications & Presentations

PubMed

1 citations
A case of annular erythema of infancy accompanied by elevated tryptase.
Jacob T Kingsley, Erica B Lee, Jennifer L Adams
Pediatric Dermatology. 2022-09-01
Disseminated Histoplasmosis Diagnosed by "Touch Prep".
Jacob Kingsley, Dillon Clarey, Scott R. Lauer, Ryan M. Trowbridge
The American Journal of Dermatopathology. 2020-08-01

Abstracts/Posters

Rapid Improvement of Scleromyxedema Associated with IgG Kappa Monogammopathy after Intravenous Immunoglobulin (IVIG)
Jacob Kingsley, Robert Borucki, Dillon Clarey, Megan Arthur, UNMC GME Research Symposium, 5/4/2022
The Predictive Role of Cutaneous IgA Deposition in Leukocytoclastic Vasculitis with Respect to Renal Involvement: A Systematic Review of the Current Evidence
Rachel Samuelson, Jacob Kingsley, Dillon Clarey, Megan Arthur, American Academy of Dermatology, 9/1/2021

Professional Memberships

Alpha Omega Alpha Honor Medical Society - AOA
Member
American Medical Association - AMA
Member
American Academy of Dermatology - AAD
Member

Jacob Kingsley MD (He/Him)

Dr. Kingsley is on Doximity

Education & Training

Certifications & Licensure

Clinical Trials

Publications & Presentations

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.